Actively Recruiting
GnRH for Luteal Support in IVF/ICSI/FET Cycles
Led by University Reproductive Associates · Updated on 2025-08-01
350
Participants Needed
1
Research Sites
556 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .
CONDITIONS
Official Title
GnRH for Luteal Support in IVF/ICSI/FET Cycles
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women undergoing IVF, ICSI, or frozen embryo transfer (FET) treatment
- Age less than 40 years
You will not qualify if you...
- Embryo transfers performed on day 3 after fertilization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Reproductive Associates
Hasbrouck Heights, New Jersey, United States, 07604
Actively Recruiting
Research Team
P
Peter G McGovern, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here